New Insights into Inflammatory Bowel Disease

The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknow...

Full description

Saved in:
Bibliographic Details
Other Authors: Huber, Samuel (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2016
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_129355
005 20231201
003 oapen
006 m o d
007 cr|mn|---annan
008 20231201s2016 xx |||||o ||| 0|eng d
020 |a 61540 
020 |a 9789535127550 
020 |a 9789535127543 
020 |a 9789535141679 
040 |a oapen  |c oapen 
024 7 |a 10.5772/61540  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJJ  |2 bicssc 
100 1 |a Huber, Samuel  |4 edt 
700 1 |a Huber, Samuel  |4 oth 
245 1 0 |a New Insights into Inflammatory Bowel Disease 
260 |b IntechOpen  |c 2016 
300 |a 1 electronic resource (264 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknown. However, it is clear that the pathogenesis is complex, involving barrier defects, changes in the intestinal microbiome, and chronic immune activation. This book aims to summarize basic aspects of these complex interactions between barrier function, microbiome, and the immune system. Of note, there is currently no cure for IBD. However, several therapies have evolved in the last years, which are overall able to-at least temporarily-suppress IBD. These therapies and the underlying mechanism are discussed. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Hepatology  |2 bicssc 
653 |a cytokines, crohn's disease, ulcerative colitis, th17, epidemiology, pathogenesis 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/5204/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/129355  |7 0  |z DOAB: description of the publication